Idiopathic dilated cardiomyopathy

GW Dec, V Fuster - New England Journal of Medicine, 1994 - Mass Medical Soc
Idiopathic dilated cardiomyopathy (IDC) is a primary myocardial disease of unknown cause
characterized by left ventricular or biventricular dilatation and impaired myocardial …

Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure

JS Floras - Journal of the American College of Cardiology, 1993 - Elsevier
Proposed reflex mechanisms for generalized neurohumoral activation in heart failure
include decreased input from inhibitory baroreceptor afferent vessels and increased input …

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

M Ungerer, M Böhm, JS Elce, E Erdmann, MJ Lohse - Circulation, 1993 - Am Heart Assoc
BACKGROUND In chronic heart failure, the positive inotropic effects of beta-adrenergic
receptor agonists are greatly reduced, in part as a result of two alterations of the cardiac beta …

Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction

SM Dunlay, VL Roger, SA Weston, R Jiang… - Circulation: Heart …, 2012 - Am Heart Assoc
Background—Heart failure (HF) can occur in patients with preserved (HFpEF, EF≥ 50%) or
reduced (HFrEF, EF< 50%) ejection fraction (EF), but changes in EF after HF diagnosis are …

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

BD Lowes, W Minobe, WT Abraham… - The Journal of …, 1997 - Am Soc Clin Investig
Using quantitative RT-PCR in RNA from right ventricular (RV) endomyocardial biopsies from
intact nonfailing hearts, and subjects with moderate RV failure from primary pulmonary …

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE trial

M Packer, WS Colucci, JD Sackner-Bernstein, C Liang… - Circulation, 1996 - Am Heart Assoc
Background Carvedilol has improved the symptomatic status of patients with moderate to
severe heart failure in single-center studies, but its clinical effects have not been evaluated …

Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.

BA Kingwell, JM Thompson, DM Kaye, GA McPherson… - Circulation, 1994 - Am Heart Assoc
BACKGROUND Although heart rate variability (HRV) at 0.1 Hz has been proposed as a
noninvasive clinical measure of cardiac sympathetic nerve firing, this premise has not been …

Absence of low-frequency variability of sympathetic nerve activity in severe heart failure

P Van De Borne, N Montano, M Pagani, R Oren… - Circulation, 1997 - Am Heart Assoc
Background In normal humans, variability of blood pressure, RR interval, and sympathetic
activity occurs predominantly at a low frequency (LF; 0.04 to 0.14 Hz) and a high frequency …

Mechanism of action of beta-blocking agents in heart failure

MR Bristow - The American journal of cardiology, 1997 - Elsevier
Antiadrenergic treatment is currently an emerging and very promising approach to the
treatment of chronic heart failure. Although the adrenergic nervous system can be …

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins

J van der Velden, Z Papp, R Zaremba… - Cardiovascular …, 2003 - academic.oup.com
Objective: The alterations in contractile proteins underlying enhanced Ca2+-sensitivity of the
contractile apparatus in end-stage failing human myocardium are still not resolved. In the …